# Novartis invests EUR 53 million in La Almunia plant expansion

Novartis is investing EUR 53 million to expand its radioligand therapy plant in La Almunia de Doña Godina, Spain, increasing production capacity fivefold and doubling export capacity. The expansion is expected to be completed in 2025.

- Type: Expansion
- Announced: 2025-02-04
- Where: La Almunia de Doña Godina, Zaragoza, Spain
- Value: $57.0M (53.0M EUR)
- Starts operating: 2025
- Status: under construction
- Capacity: five times current capacity
- Products: radioligand therapies for cancer treatment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novartis](https://endata.com/companies/32041.md)

## Sources

- [eldiario.es](https://www.eldiario.es/aragon/sociedad/novartis-invertira-53-millones-euros-planta-almunia-multiplicar-cinco-capacidad_1_12025875.html), 2025-02-04: "La planta de La Almunia de Doña Godina es una instalación clave para el liderazgo de Novartis en terapias con radioligandos."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.